rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

BrainsWay Ltd. - American Depositary Shares

BWAY · Nasdaq

Health CareMedical DevicesNot moving yetNeurotech

BWAY stood above a rising 150-day average in 44 of the last 52 weekly readings, and has been out of that trend for the last 8 weeks. It is 21.6% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 8
Industry in uptrend
27% -9 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
52 (+4)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 44 of 52 weeks.

17 Apr – 16 Oct
19%29%40%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months5
Buyers · sellers0 · 3
WhoDidSharesTraded
Gilad MoiseyevChief Technology Officersold5,00015 Jun 2026filed 22 Jun 2026
Yiftach RothChief Scientistsold1,0002 Jun 2026filed 3 Jun 2026
Yiftach RothChief Scientistsold2,0002 Jun 2026filed 3 Jun 2026
Yiftach RothChief Scientistsold2,0001 Jun 2026filed 3 Jun 2026
Yiftach RothChief Scientistsold2,0001 Jun 2026filed 3 Jun 2026
Rayten Michal Ety MitranyDirectorsold7,98026 May 2026filed 26 May 2026
Rayten Michal Ety MitranyDirectorsold10,00025 May 2026filed 26 May 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders52+4 on the quarter
New · exited10 · 6
Reported value$163.2M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Valor Management LLCunchanged · filed 14 Aug 20265,314,950$82.4M00.0%
MASTERS CAPITAL MANAGEMENT LLCreduced · filed 14 Aug 20261,500,000$23.3M-150,000−9.1%
ESSEX INVESTMENT MANAGEMENT CO LLCreduced · filed 6 Aug 2026592,606$9.2M-25,947−4.2%
RENAISSANCE TECHNOLOGIES LLCreduced · filed 13 Aug 2026475,920$7.4M-42,500−8.2%
Cresset Asset Management, LLCunchanged · filed 14 Aug 2026314,924$4.9M00.0%
Y.D. More Investments Ltdreduced · filed 5 Aug 2026237,433$3.7M-34,571−12.7%
Legato Capital Management LLCadded · filed 6 Aug 2026197,635$3.1M+5,485+2.9%
MORGAN STANLEYadded · filed 13 Aug 2026188,968$2.9M+84,574+81.0%
EAGLE GLOBAL ADVISORS LLCadded · filed 30 Jul 2026182,606$2.8M+10,000+5.8%
ARK Investment Management LLCreduced · filed 14 Aug 2026142,500$2.2M-51,186−26.4%
31 Mar 2023 – 30 Jun 2026
123251Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Gilad Moiseyev Company insiderChief Technology Officer · last 15 Jun 20260 · 1
Yiftach Roth Company insiderChief Scientist · last 2 Jun 20260 · 2
Rayten Michal Ety Mitrany Company insiderDirector · last 26 May 20260 · 2

Same industry

RCEL Avita MedicalLeading+100%
ATRC AtriCureLeading+49%
HAE HaemoneticsLeading+48%
HTFL HeartflowLeading+40%

Distance from each stock’s own 150-day average.

From its SEC filings

Share count trendFY 2025 · to 31 Dec 20254.1%

Analyst forecasts

No analyst forecasts yet.